Can You Take Aspirin With High Blood Pressure?

Aspirin does not raise blood pressure, and taking it alongside blood pressure medication is generally safe from a drug-safety standpoint. The real question is whether aspirin is a good idea for you, which depends almost entirely on whether you already have cardiovascular disease or are trying to prevent it from developing in the first place. That distinction, between secondary and primary prevention, has reshaped medical guidance over the past decade and catches many people off guard.

Does Aspirin Actually Affect Blood Pressure?

One of the most common worries is that aspirin, like ibuprofen or naproxen, might push blood pressure up. The concern is reasonable because several over-the-counter painkillers in the same broad family of anti-inflammatory drugs do interfere with blood pressure control. Aspirin, however, appears to be the exception. A meta-analysis of randomized trials looking at NSAIDs and blood pressure found that aspirin’s average effect was negligible.

A more recent systematic review and meta-analysis focused specifically on hypertensive patients confirmed the same thing: pooled results showed no meaningful change in either systolic or diastolic blood pressure among people taking aspirin compared to those who were not.¹ So if you are on blood pressure medication and your doctor has you on aspirin, the aspirin itself is unlikely to undermine your pressure readings.

Primary Prevention Has Changed Dramatically

For decades, low-dose aspirin was handed out almost reflexively to people with high blood pressure or other risk factors for heart disease, even if they had never had a heart attack or stroke. That era is over. Multiple large trials enrolling higher-risk groups, including older adults and people with diabetes, consistently showed the same pattern: aspirin’s ability to prevent a first cardiovascular event was marginal, and in most people the benefit was offset by a higher risk of serious bleeding.² A review in Arteriosclerosis, Thrombosis, and Vascular Biology put it plainly: aspirin protects against blood clots but increases the risk of major bleeding, and for primary prevention in broad populations the risk outweighs the benefit.³

Current guidance from the American College of Cardiology and the American Heart Association reflects this shift. Low-dose aspirin (75 to 100 mg per day) might be considered for primary prevention in select adults aged 40 to 70 who are at higher cardiovascular risk but not at increased risk of bleeding. For adults over 70, routine primary-prevention aspirin is not recommended. The same goes for anyone of any age who already faces elevated bleeding risk.⁴

A benefit-harm modeling study helps illustrate just how individual this calculation is. Among people without existing cardiovascular disease, roughly one in eight men and one in forty women were predicted to have a net benefit from five years of aspirin use, assuming a single prevented heart attack is equivalent in severity to one major bleed. The people most likely to benefit had higher cardiovascular risk and lower bleeding risk, which is a narrower slice of the population than most people assume.⁵

Secondary Prevention Is a Different Story

If you have already had a heart attack, stroke, or been diagnosed with atherosclerotic cardiovascular disease, aspirin remains a standard part of treatment. The evidence here is far stronger and less ambiguous than for primary prevention.

The landmark Hypertension Optimal Treatment (HOT) trial, which enrolled nearly 19,000 people with hypertension, found that adding low-dose aspirin reduced major cardiovascular events by about 15% and cut heart attacks by roughly a third, with no significant effect on stroke.⁶ The trade-off was a notable increase in non-fatal major bleeds, a pattern that has held across virtually every aspirin trial.

For people already on aspirin for secondary prevention, the question of dose has been studied in the ADAPTABLE trial, which randomized over 15,000 patients with cardiovascular disease to either 81 mg or 325 mg daily. In adults 65 and older, the low dose performed comparably to the higher dose, while in adults under 65, there was a slight signal favoring the higher dose, though the overall event rates were similar.⁷ For most people, the 81 mg “baby aspirin” dose remains the default.

The Bleeding Risk Is Real and Increases With Age

Aspirin works by making platelets less sticky, which is exactly why it prevents clots and exactly why it promotes bleeding. For otherwise healthy people over 70, the ASPREE trial documented a 60% overall increase in major gastrointestinal bleeding among those randomized to aspirin. The absolute five-year risk of a major GI bleed ranged from about 0.25% for a 70-year-old not on aspirin to as high as 5% for an 80-year-old taking aspirin who also had additional risk factors like smoking, high blood pressure, kidney disease, or obesity.⁸

The reassuring counterpoint is that aspirin-related GI bleeds, while more frequent, do not appear to be more fatal. A meta-analysis of randomized prevention trials found no significant increase in fatal GI bleeds attributable to low-dose aspirin. The rate of death from a GI bleed was actually slightly lower numerically in the aspirin group, though the difference was not statistically significant.⁹ So the bleeds are overwhelmingly survivable, but they still land people in hospitals, sometimes require transfusions, and can be frightening.

Interactions With Blood Pressure Medications

One interaction worth knowing about involves ACE inhibitors, a class of blood pressure drugs that includes enalapril, lisinopril, and ramipril. Early studies suggested that aspirin at higher doses (300 mg or more) could blunt the blood-pressure-lowering and heart-protecting effects of these drugs.¹⁰ A large collaborative meta-analysis of major trials later investigated this question and found that the concern, while biologically plausible, did not clearly translate into worse outcomes for patients taking both medications at standard doses.¹¹

In practice, millions of people take low-dose aspirin alongside ACE inhibitors or ARBs (a related drug class) without any dose adjustment. The interaction concern was most relevant at higher aspirin doses that are rarely used today for cardiovascular prevention. If you are on an ACE inhibitor and a standard 81 mg aspirin, this is not generally considered a problematic combination, but it is worth mentioning to your doctor so they can monitor your blood pressure trend.

Does It Matter When You Take Aspirin?

A recurring idea in cardiology is that taking aspirin at bedtime, rather than in the morning, might actually lower blood pressure. Some meta-analyses have supported this. One pooled analysis found that bedtime aspirin reduced systolic blood pressure by roughly 3.5 to 4 mmHg compared to morning dosing, with low statistical inconsistency across studies.¹² An earlier meta-analysis found a similar pattern, with bedtime aspirin lowering systolic pressure by nearly 4 mmHg relative to no aspirin, while morning aspirin showed essentially no blood pressure effect.¹³

But the story is more complicated than those pooled numbers suggest. A well-designed randomized crossover trial found no difference in blood pressure between bedtime and morning aspirin in patients with cardiovascular disease.¹⁴ A more recent meta-analysis helped clarify the discrepancy: the blood pressure drop from bedtime aspirin was concentrated in people with untreated or prehypertensive blood pressure. Among people already on blood pressure medication or with established cardiovascular disease, the timing made no meaningful difference.¹⁵

What this likely means for most people with hypertension who are already taking blood pressure medication: it probably does not matter when you take your aspirin. But if you have elevated blood pressure that is not yet being treated with drugs, bedtime dosing might offer a small additional benefit. This remains an area of active investigation rather than firm guideline.

Aspirin Resistance in People With Hypertension

Not everyone responds to aspirin the same way. A phenomenon called aspirin resistance means that in some people, aspirin fails to adequately suppress platelet activity. Research has found that hypertension itself appears to be a risk factor. One study of 134 patients with stable coronary artery disease found aspirin resistance in about 16% overall, but the rate was significantly higher in hypertensive patients.¹⁶

A separate study of 200 hypertensive patients found aspirin resistance in 21% of the group. Poorly controlled blood pressure was associated with a somewhat higher resistance rate than well-controlled pressure, though the difference did not reach statistical significance. Female sex and higher creatinine levels (a marker of reduced kidney function) were independent predictors of resistance.¹⁷ This does not mean you should double your aspirin dose on your own. It does mean that if you are taking aspirin for secondary prevention and have poorly controlled blood pressure, getting that pressure down is important for multiple reasons, including making sure the aspirin is doing its job.

Aspirin During Pregnancy With High Blood Pressure

Aspirin occupies a unique role in pregnancy, where it is one of the few medications actively recommended for women at high risk of preeclampsia, a dangerous pregnancy complication characterized by high blood pressure and organ damage. Low-dose aspirin started early in pregnancy has accumulated growing evidence for reducing preeclampsia risk.¹⁸

For women who already have chronic hypertension before becoming pregnant, the evidence is particularly relevant. A recent integrative review found that aspirin doses of 150 mg or more, started before 12 weeks of pregnancy and taken at bedtime, showed the most promising results for reducing preeclampsia in this population.¹⁹ Guidelines vary between countries on the exact dose and timing, and this is emphatically a decision to make with an obstetrician, not something to self-prescribe. But the general direction of the evidence is that aspirin can be beneficial during pregnancy for women with hypertension, which is the opposite of what many people assume about taking any medication while pregnant.

Blood Pressure Control Matters for Dual Antiplatelet Therapy

Some patients, particularly after a mini-stroke or minor ischemic stroke, are placed on dual antiplatelet therapy, typically aspirin plus clopidogrel, for a short period. An analysis from the POINT trial found that blood pressure at the time of treatment significantly influenced outcomes. Among patients with systolic blood pressure below 140 mmHg, dual therapy reduced the risk of recurrent ischemic stroke dramatically compared to aspirin alone. But for patients with systolic pressure at or above 140, the benefit shrank considerably and the risk of major hemorrhage increased threefold.²⁰

The takeaway is straightforward: when blood pressure is well controlled, antiplatelet drugs work better and cause fewer problems. This reinforces a point that applies broadly. Aspirin’s safety and effectiveness in people with hypertension depends substantially on how well the hypertension itself is managed.

The Self-Prescribing Problem

A striking finding from a study of older African American adults was that 60% of low-dose aspirin users were taking it on their own, without a clinician’s prescription.²¹ Because aspirin is cheap, familiar, and available without a prescription, many people with high blood pressure start taking it as a preventive measure without discussing it with a doctor. Given how much the risk-benefit equation has shifted against routine primary prevention, this is a real concern. The aspirin you are taking “just in case” may be providing minimal cardiovascular protection while meaningfully raising your chance of a GI bleed, especially if you are over 70, take other NSAIDs, or have kidney issues.

An e-health intervention trial targeting older adults with hypertension found that education significantly reduced the frequency of daily NSAID use among patients who were not meeting their blood pressure targets.²² That study targeted NSAIDs broadly rather than aspirin specifically, but it highlights a pattern: many older adults with hypertension are taking over-the-counter medications daily without fully appreciating the interaction with their blood pressure control. A conversation with your doctor about what you are actually taking, including supplements and over-the-counter pills, is genuinely useful.

Why Stopping Aspirin Abruptly Can Be Dangerous

If you are on aspirin for secondary prevention and are considering stopping, do not do it abruptly without medical guidance. A meta-analysis found that aspirin withdrawal preceded up to about 10% of acute cardiovascular events in retrospective studies. The timing was fast: acute coronary events occurred an average of about 8 to 9 days after stopping, and acute cerebrovascular events around 14 days after discontinuation.²³

This rebound effect is thought to be related to a surge in platelet activity once aspirin’s suppressive effect wears off. Surgeons and dentists sometimes ask patients to stop aspirin before procedures, and in many cases the bleeding risk from continuing aspirin is actually lower than the cardiovascular risk from stopping it. If a healthcare provider tells you to pause your aspirin before a procedure, ask whether the cardiovascular risk has been weighed against the surgical bleeding risk. In plenty of situations, low-dose aspirin can be safely continued.

Kidney Disease Adds Another Layer

Many people with longstanding hypertension develop some degree of chronic kidney disease, which complicates the aspirin calculus in an interesting way. A post-hoc analysis of the HOT trial found that aspirin’s cardiovascular benefit increased as kidney function declined. Among patients with the most impaired kidney function, aspirin reduced major cardiovascular events by about two-thirds and cut total mortality by roughly half. The trade-off was a higher bleeding rate in these patients, but the net benefit was still strongly positive: for every 1,000 patients with significantly reduced kidney function treated for about four years, an estimated 76 major cardiovascular events and 54 deaths would be prevented at the cost of 27 excess major bleeds.²⁴

This finding is based on a subgroup analysis of a single trial, so it warrants some caution. But it suggests that for people with both hypertension and impaired kidney function, aspirin may carry a more favorable benefit-to-risk ratio than for the general hypertensive population. It also underscores that “should I take aspirin” cannot be answered with a blanket yes or no. The right answer depends on your cardiovascular risk, your bleeding risk, your kidney function, your age, and your existing medications, all assessed together rather than in isolation.